About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 683 record(s)
Req # A-2023-000942
Any medical device establishment license held by SureScreen Corporation from 2012 to 2022 inclusive.Organization: Health Canada
November 2023
Req # A-2023-000969
The full list of the serum ingredients provided by and used in conjunction with AlmaTED a medical device recently approved by Health Canada as as a non-invasive hair loss treatment in Canada.Organization: Health Canada
November 2023
Req # A-2023-000975
All meeting notes, minutes, summaries and briefings regarding the meetings of the Selection Committee that met to review bids for Solicitation Number 6D063-204744, Title: "Request For Standing Offer - Rapid Test Covid-19".Organization: Health Canada
November 2023
Req # A-2023-000978
Certain information related to the status of this company's file with your agency. Company: Enterprise: Les Entreprises De Réfrigération L.S. inc. (NEQ: 1178471000). 1610 Gallant St., Laval, QC H7L 5B2. 3149 Delaunay St., Laval, QC H7L 5A4Organization: Health Canada
November 2023
Req # A-2023-000994
The Section 1.0.7 “Note to the Reviewer” (Module 1.0.7) from the generic manufacturer of the Estradiol Abbreviated New Drug Submission (ANDS) which appears on the Generic Submissions Under Review (GSUR) List.Organization: Health Canada
November 2023
Req # A-2023-000997
Details concerning all proceedings, requests or recourse currently active, underway or pending or any balance owing to you by the company 9226-6709 Québec Inc. (NEQ: 1166807389). Address: 515 l'Avenir St., Québec, QC G1E 5E8.Organization: Health Canada
November 2023
Req # A-2023-001044
Obtain details concerning all proceedings, requests or recourse currently active, underway or pending or any balance owing to you by the company. Company: Maison Isabelle inc. (NEQ: 1176226232). 95 Radnor St., Trois-Rivières, QC G8T 2E6.Organization: Health Canada
November 2023
Req # A-2023-000821
Information as to whether or not the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review in August 2017 is on “intellectual property hold” as described in section 6.2 of Health Canada’s Guidance Document on Patented Medicines…Organization: Health Canada
October 2023
Req # A-2023-000846
All communications between Health Canada personnel and "Régie de l'assurance maladie du Québec" (RAMQ) personnel that deal with one or more of the following topics: controlled distribution of drugs; notices of compliance with…Organization: Health Canada
October 2023
Req # A-2023-000861
All electronic communications within the Public Health Agency of Canada with respect to the Member of Parliament (MP) Michelle Rempel Garner's Substack article entitled "The Public Health Agency of Canada has a trust deficit, and it could…Organization: Health Canada
October 2023